AstraZeneca Global R&D China Center officially opened​

On October 11, AstraZeneca, the world's leading multinational pharmaceutical company, announced the official opening of its Global R&D China Center in Jing'an District, Shanghai

Light-up ceremony

Zong Ming, Deputy Mayor of Shanghai, Gu Jun, Secretary of the Party Leadership Group and Director of the Shanghai Municipal Commission of Commerce, Yu Yong, Secretary of the Shanghai Jing’an District Committee, Wang Hua, Deputy Secretary of the Jing’an District Committee and Mayor of Shanghai, Zhang Jun, Deputy District Mayor of Shanghai’s Jing’an District, Hu Keding, Consul General of the British Consulate in Shanghai, attended the opening ceremony of AstraZeneca's Global R&D China Center

Opening speech by Dr.

Dr.

The upgraded AstraZeneca Global R&D China Center is undergoing rapid development

In the future, AstraZeneca’s Global R&D Center in China will continue to increase its forward-looking layout in the field of diseases with huge medical needs in China, and further use its capabilities in bioanalysis, translational medicine, artificial intelligence, big data and other fields to help global R&D and achieve nearly every year.

Video Speech by Subko

Zhang Jun, Deputy District Chief of Jing'an District, Shanghai, Hu Keding, British Consulate General in Shanghai, Wang Lei, Executive Vice President of AstraZeneca Global, President of International Business and China, delivered on-site speeches, and AstraZeneca’s global CEO, Subko, gave a video speech on global R&D.